Letosteine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
2-{2-[(2-ethoxy-2-oxoethyl)thio]ethyl}-1,3-thiazolidine-4-carboxylic acid | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 53943-88-7 |
ATC code | R05CB09 |
PubChem | CID 68707 |
ChemSpider | 61958 |
UNII | 6MVF9U95DW |
KEGG | D07380 |
Synonyms | 2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid |
Chemical data | |
Formula | C10H17NO4S2 |
Mol. mass | 279.378 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.[1] He filed his application in 2000.
References
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.